Smallpox Antiviral

Award Notice Posted

A later notice was posted: the Limited / Sole Source Justification from .

Solicitation number
75A50122R00012
Agency
Awarded
to Emergent Biodefense Operations Lansing LLC
Set-aside
No set-aside

Opportunity facts

Contract number
75A50122C00047 Federal contract award

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response announces the award of a contract to CHIMERIX, INC. to procure TEMBEXA for use as a treatment for smallpox. The contract, numbered 75A50122C00047, was awarded on August 26, 2022 for a value of $679,592,091 to supply the antiviral medication.

Notice text

Procurement of TEMBEXA as a treatment for smallpox.

Awarded contract 75A50122C00047 to CHIMERIX, INC. for 679592091.00 on 2022-08-26.

Notice history

Notice Type Posted
Smallpox Antiviral Latest Limited / Sole Source Justification
This notice Award Award Notice
Smallpox Antiviral Latest solicitation Solicitation
Smallpox Antiviral Pre-Solicitation
Smallpox Antiviral Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors